MedTrace Logo

HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding

NCT07753005 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 176

Last updated 2026-08-07

No results posted yet for this study

Summary

This observational study will collect information from adult patients in Japan who are treated with Histoacryl® to stop bleeding from arteries in the chest or abdomen, in order to better understand how well the treatment works and how safe it is during routine medical care.

Conditions

  • Hemorrhage
  • Gastrointestinal Hemorrhage
  • Hemoptysis
  • Postpartum Hemorrhage

Interventions

DEVICE

Embolization therapy

Embolization of Thoracoabdominal Artery Bleeding (TAB), excluding "Cardiac blood vessels other than Pulmonary artery", "Endoscopic esophageal varices embolization operations", and "Pulmonary artery malformation".

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Miyuki Sone, Dr. · National Cancer Center Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2028-04-30
Completion
2028-06-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07753005 on ClinicalTrials.gov